Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Phialogics Logo
Phialogics Growth Score
58
CB Rank
84852
Heat Score
41
Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.
Founded
obfuscation
PrivateGrant Allschwil, Basel-Landschaft, Switzerland1-10 www.phialogics.com/
Biotechnology
Clinical Trials
Overview

Phialogics
Total Funding
obfuscation
Growth Score
58
Heat Score
41

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score58
-6 pts
in past quarter
Heat Score 41
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Phialogics

CB Rank
84852
Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.
Founded
obfuscation
PrivateGrant Allschwil, Basel-Landschaft, Switzerland1-10 www.phialogics.com/
Biotechnology
Clinical Trials

Funding Rounds

Grant
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Details

Legal Name Phialogics AG
Operating Status Active
Company Type For Profit
About the Company
Phialogics is a preclinical biotech business with a focus on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.
Contact Email ernst@phialogics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Phia platform
A platform for developing immune modulating therapeutics targeting autoimmune diseases by activating cell-type-specific immune checkpoints to prevent multi-organ failure.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant
obfuscation
Grant - Phialogics Logo
Grant - Phialogics
1
obfuscation
BaseLaunchGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
BaseLaunch Logo
BaseLaunch
Yes
Grant - Phialogics Logo
Grant - Phialogics
—
BaseLaunch Logo
BaseLaunch
Yes
Grant - Phialogics Logo
Grant - Phialogics
—
BaseLaunch Logo
BaseLaunch
Yes
Grant - Phialogics Logo
Grant - Phialogics
—
BaseLaunch Logo
BaseLaunch
Yes
Grant - Phialogics Logo
Grant - Phialogics
—
BaseLaunch Logo
BaseLaunch
Yes
Grant - Phialogics Logo
Grant - Phialogics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•May 5, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 18, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

65

IT Spend

$131.5KThis year, Phialogics is projected to spend $131.5K on IT, according to Aberdeen.

Active Website Tech Count

3Phialogics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

1Phialogics has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Phialogics's headquarters? Phialogics is located in Allschwil, Basel-Landschaft, Switzerland.Who invested in Phialogics? Phialogics has 2 investors including BaseLaunch and  HTGF (High-Tech Gruenderfonds).When was the last funding round for Phialogics? Phialogics closed its last funding round on
obfuscation
from a Grant round.Who are Phialogics's competitors? Alternatives and possible competitors to Phialogics may include AviadoBio, Cabaletta Bio, and  Zag Bio.How much funding has Phialogics raised to date? Phialogics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|